Cargando…
PU-91 drug rescues human age-related macular degeneration RPE cells; implications for AMD therapeutics
Since mitochondrial dysfunction is implicated in the pathogenesis of AMD, this study is based on the premise that repurposing of mitochondria-stabilizing FDA-approved drugs such as PU-91, might rescue AMD RPE cells from AMD mitochondria-induced damage. The PU-91 drug upregulates PGC-1α which is a cr...
Autores principales: | Nashine, Sonali, Subramaniam, Sudhakar R., Chwa, Marilyn, Nesburn, Anthony, Kuppermann, Baruch D., Federoff, Howard, Kenney, M. Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756897/ https://www.ncbi.nlm.nih.gov/pubmed/31477635 http://dx.doi.org/10.18632/aging.102179 |
Ejemplares similares
-
Role of Resveratrol in Transmitochondrial AMD RPE Cells
por: Nashine, Sonali, et al.
Publicado: (2020) -
Humanin G (HNG) protects age-related macular degeneration (AMD) transmitochondrial ARPE-19 cybrids from mitochondrial and cellular damage
por: Nashine, Sonali, et al.
Publicado: (2017) -
Potential Therapeutic Functions of PU-91 and Quercetin in Personalized Cybrids Derived from Patients with Age-Related Macular Degeneration, Keratoconus, and Glaucoma
por: Salimiaghdam, Nasim, et al.
Publicado: (2023) -
Differential Expression of Complement Markers in Normal and AMD Transmitochondrial Cybrids
por: Nashine, Sonali, et al.
Publicado: (2016) -
Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration
por: Nashine, Sonali, et al.
Publicado: (2018)